Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Antiviral Nucleoside Inhibitors01:22

Antiviral Nucleoside Inhibitors

Antiviral Nucleoside InhibitorsAntiviral nucleoside inhibitors are structural analogs of natural nucleosides that interfere with viral DNA or RNA synthesis. These compounds selectively target viral polymerases due to their resemblance to host nucleosides, thereby disrupting viral genome replication.Mechanism of Acyclovir ActionAcyclovir is a guanosine analog with a three-carbon acyclic side chain. It selectively targets herpes simplex virus type 1 (HSV-1), herpes simplex virus type 2 (HSV-2),...
Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
Cancer02:18

Cancer

Cancers arise due to mutations in genes involved in the regulation of cell division, which leads to unrestricted cell proliferation. Modern science and medicine have made great strides in the understanding and treatment of cancer, including eradicating cancer in some patients. However, there is still no cure for cancer. This is largely due to the fact that cancer is a large group of many diseases.
Cancer Prevention02:59

Cancer Prevention

Several factors can increase the risk of cancer in an individual. About 50% of cancer cases can be prevented by adopting a healthy lifestyle, regular exercise, eating healthy, and following a modest cancer prevention diet. Epidemiological studies have consistently shown that populations with vegetable and fruit-rich diets have reduced the incidence of cancer. On the other hand, populations who have a diet rich in animal fat, red meat, junk food, or high calories are predisposed to cancer.
Some...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Discovery of the efficacious component group of Bu Fei formula and its mechanism of ameliorating chronic obstructive pulmonary disease by inhibiting the IL-33 pathway.

Journal of chromatography. B, Analytical technologies in the biomedical and life sciences·2026
Same author

Discovery of an isoflavone biosynthetic pathway in Iridaceae plants.

Nature communications·2026
Same author

Corrigendum to "Screening of antithrombotic components from Typhae Pollen by a multidimensional evaluation strategy" [J. Ethnopharmacol. 369 (2026) 121868].

Journal of ethnopharmacology·2026
Same author

The antiphage mechanism of a widespread trypsin-MBL defense module.

Nature chemical biology·2026
Same author

Comparative analysis of lipid-lowering mechanisms in efficacy-divergent traditional Chinese medicines.

Phytomedicine : international journal of phytotherapy and phytopharmacology·2026
Same author

Screening of antithrombotic components from Typhae Pollen by a multidimensional evaluation strategy.

Journal of ethnopharmacology·2026

Related Experiment Video

Updated: Jun 15, 2026

Cellular Membrane Affinity Chromatography Columns to Identify Specialized Plant Metabolites Interacting with Immobilized Tropomyosin Kinase Receptor B
11:44

Cellular Membrane Affinity Chromatography Columns to Identify Specialized Plant Metabolites Interacting with Immobilized Tropomyosin Kinase Receptor B

Published on: January 19, 2022

Anticancer agents derived from natural products.

E-Hu Liu1, Lian-Wen Qi, Qian Wu

  • 1Key Laboratory of Modern Chinese Medicines, China Pharmaceutical University, Ministry of Education, No. 24, Tongjia Lane, Nanjing 210009, China.

Mini Reviews in Medicinal Chemistry
|March 9, 2010
PubMed
Summary
This summary is machine-generated.

Natural products like Taxol and curcumin offer promising anticancer activities. This review details their mechanisms, structures, and potential for cancer prevention and treatment.

More Related Videos

A Fluorescence-based Protocol for Preliminary Screening of Protein Synthesis Inhibitors from Natural Sources
10:24

A Fluorescence-based Protocol for Preliminary Screening of Protein Synthesis Inhibitors from Natural Sources

Published on: January 27, 2026

Generation of Monoclonal Antibodies Against Natural Products
12:15

Generation of Monoclonal Antibodies Against Natural Products

Published on: April 6, 2019

Related Experiment Videos

Last Updated: Jun 15, 2026

Cellular Membrane Affinity Chromatography Columns to Identify Specialized Plant Metabolites Interacting with Immobilized Tropomyosin Kinase Receptor B
11:44

Cellular Membrane Affinity Chromatography Columns to Identify Specialized Plant Metabolites Interacting with Immobilized Tropomyosin Kinase Receptor B

Published on: January 19, 2022

A Fluorescence-based Protocol for Preliminary Screening of Protein Synthesis Inhibitors from Natural Sources
10:24

A Fluorescence-based Protocol for Preliminary Screening of Protein Synthesis Inhibitors from Natural Sources

Published on: January 27, 2026

Generation of Monoclonal Antibodies Against Natural Products
12:15

Generation of Monoclonal Antibodies Against Natural Products

Published on: April 6, 2019

Area of Science:

  • Natural product chemistry
  • Pharmacology
  • Oncology

Background:

  • Natural products have historically been a vital source of anticancer drugs.
  • Advances in technology facilitate the discovery and development of new natural product-derived cancer therapeutics.
  • There is a continuous need for novel chemopreventive and chemotherapeutic agents.

Purpose of the Study:

  • To review the anticancer activities, mechanisms of action, and structure-activity relationships of six key natural product-derived anticancer agents.
  • To highlight the significance of natural products in cancer research and drug development.

Main Methods:

  • Literature review of scientific publications on natural product anticancer agents.
  • Analysis of data on anticancer activities, mechanisms, and structure-activity relationships.
  • Focus on six specific agents: Taxol, betulinic acid, camptothecin, resveratrol, podophyllotoxin, and curcumin.

Main Results:

  • Detailed presentation of the anticancer properties of the selected natural products.
  • Explanation of their diverse mechanisms of action at the molecular level.
  • Discussion of how structural modifications impact their efficacy and activity.

Conclusions:

  • Natural products remain a crucial resource for discovering effective anticancer agents.
  • Understanding structure-activity relationships is key to optimizing these compounds for therapeutic use.
  • These agents hold significant potential for advancing cancer prevention and treatment strategies.